Introduction: the product was first developed in China by Beiriku Pharmaceutical Co., Ltd. It is used in magnetic resonance abdominal examination. It is a double relative contrast agent: positive contrast agent in T1 examination and negative contrast agent in T2 examination.
Indications: Magnetic resonance imaging of the abdomen, the gastrointestinal tract (stomach, duodenum and jejunum).
Usage and Dosage: For adults, take one bag, dissolved in 300ml water, orally.If necessary, take 2 bags orally, dissolved in the same amount of water.MRI is usually performed within 5 to 20 minutes of taking the drug.
Adverse reaction: foreign clinical data reported that 0.1-0.5% of patients appeared diarrhea;0.1% showed nausea, vomiting and decreased appetite.Very few patients have stomach discomfort and abdominal distension.The above symptoms can be resolved spontaneously.
Taboo:
1) Excess iron load,
2) People with iron allergy,
3) Patients with or suspected of complete intestinal obstruction or perforation.
Note:
1. Use with caution in the following patients: gastrointestinal patients with peptic ulcer, peptic colitis, local enteritis and other gastrointestinal patients.
2. Black stool appears after administration, which is a normal phenomenon.
3. Possible false positive occult blood.
智藥研習社官方微信
制藥在線(xiàn)官方微信
2006-2025 上海博華國際展覽有限公司版權所有（保留一切權利）
滬ICP備05034851號-57
